共 50 条
- [33] Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab BIOLOGICS-TARGETS & THERAPY, 2016, 10 : 33 - 52
- [34] The safety profile of vedolizumab in ulcerative colitis and Crohn's disease: 4 years of post-marketing data AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S4 - S4
- [35] Aminosalicylates in the treatment of ulcerative colitis and Crohn's disease ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 201 - 209
- [37] The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (08): : 123 - 133
- [38] Effects of Increased Vedolizumab Dosing Frequency on Disease Activity in Ulcerative Colitis and Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S478 - S479
- [39] Reductions in Corticosteroid Use in Patients with Ulcerative Colitis or Crohn's Disease Treated with Vedolizumab AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S503 - S503
- [40] Real-World Treatment Persistence with Vedolizumab in Patients with Ulcerative Colitis and Crohn's Disease: A Retrospective Claims Analysis in the US AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S322 - S324